On the role of brain catecholamines in motor activity: Experiments with inhibitors of synthesis and of monoamine oxidase

[1]  T. Svensson,et al.  An investigation of a new instrument to measure motor activity of small animals , 2004, Psychopharmacologia.

[2]  H. Corrodi,et al.  Central effects of an inhibitor of tyrosine hydroxylation , 2004, Psychopharmacologia.

[3]  B. Waldeck,et al.  Further studies on the possible interaction between dopamine and noradrenaline containing neurons in the brain. , 1970, European journal of pharmacology.

[4]  B. Waldeck,et al.  Is there an interaction between dopamine and noradrenaline containing neurons in the brain? , 1970, Acta physiologica Scandinavica.

[5]  T. Svensson,et al.  On the significance of central noradrenaline for motor activity: experiments with a new dopamine beta-hydroxylase inhibitor. , 1969, European journal of pharmacology.

[6]  K. E. Moore,et al.  Effects of disulfiram and diethyldithiocarbamate on spontaneous locomotor activity and brain catecholamine levels in mice. , 1969, Biochemical pharmacology.

[7]  B. Waldeck,et al.  The use of 3H-dopa for studying cerebral catecholamine metabolism. , 2009, Acta pharmacologica et toxicologica.

[8]  L. Seiden,et al.  Effects of diethyldithiocarbamate on the conditioned avoidance response of the rat , 1968, The Journal of pharmacy and pharmacology.

[9]  A. Sjoerdsma,et al.  End-product inhibition of tyrosine hydroxylase as a possible mechanism for regulation of norepinephrine synthesis. , 1967, Molecular pharmacology.

[10]  T. Hökfelt,et al.  Increased impulse flow in bulbospinal noradrenaline neurons produced by catecholamine receptor blocking agents. , 1967, European journal of pharmacology.

[11]  T. Hökfelt,et al.  Failure of dopamine to accumulate in central noradrenaline neurons after depletion with diethyldithiocarbamate , 1967, The Journal of pharmacy and pharmacology.

[12]  K. E. Moore,et al.  Antagonism by monoamine oxidase inhibitors of alpha-methyltyrosine-induced catecholamine depletion and behavioral depression. , 1967, The Journal of pharmacology and experimental therapeutics.

[13]  K. E. Moore,et al.  ALTERATIONS IN BEHAVIOR AND BRAIN CATECHOLAMINE LEVELS IN RATS TREATED WITH α-METHYLTYROSINE , 1966 .

[14]  H. Corrodi.  Blockade of the psychotic syndrome caused by nialamide in mice , 1966, The Journal of pharmacy and pharmacology.

[15]  A. Hordern.  The antidepressant drugs. , 1965, International journal of psychiatry.

[16]  K. E. Moore,et al.  Effects of α-methyltyrosine on brain catecholamines and conditioned behavior in guinea pigs , 1966 .

[17]  O. H. Spoerl.  The antidepressant drugs. , 1966, Northwest medicine.

[18]  N. Andén,et al.  Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatum☆ , 1964 .

[19]  A. Carlsson,et al.  In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine. , 1962, Acta physiologica Scandinavica.

[20]  Å. Bertler,et al.  A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. , 1958, Acta physiologica Scandinavica.

[21]  A. Carlsson,et al.  A fluorimetric method for the determination of dopamine (3-hydroxytyramine). , 1958, Acta physiologica Scandinavica.